ClinicalTrials.gg
RecruitingNCT06273007PartoMa-EthUpdated Feb 22, 2024

Improving Intrapartum Care for Saving Life at Birth in Ethiopia Through PartoMa Approach

An interventional study of PartoMa intervention(Locally achievable intrapartum care guideline), in house LDHF trainings in Stillbirth, Obstetric Complication and Maternal Death, sponsored by Haramaya Unversity. Recruiting at 2 sites in Ethiopia. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2024-02-22.

Sponsored by Haramaya Unversity · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Registered 8 months after the study started (first participant enrolled Jun 2023, registered Feb 2024).
  • Started Jun 2023; still recruiting 3 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Non-randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

Overall Objective

To introduce PartoMa approach (locally agreed and achievable intrapartum guidelines and a continual in-house training program) to Ethiopian context through continuous fetal heart rate (FHR) monitoring using MOYO device and co-creation of context specific intrapartum care guideline for improving decision making in intrapartum care in Eastern Ethiopia.

Interventions

  1. Locally agreed and achievable intrapartum guidelines
  2. Low dose high frequency trainings (LDHF)
  3. Partograph Overall Design

A quasi-experimental pre-post study (PartoMa study)

Setting

Department of Obstetrics and Gynaecology Haramaya Hospital and Hiwot Fana University Hospital, Ethiopia.

Population

Laboring women delivering at the study site from February 2023 to March 2025 and their offspring, as well as health providers. Women and their offspring will be enrolled at/after onset of labour and followed until discharge.

Endpoints

The primary endpoint is perinatal mortality. For further description and secondary outcomes, please see below.

Study Time

Data collection from June 2023 to May 2025.

Specific Objectives i. To assess FHR monitoring practice and use of obstetric guideline for decision making in Hiwot Fana University Hospital ii. To improve feto-maternal outcome through applying PartoMa approach in Hiwot Fana University Hospital.

iii. To determine the feasibility, acceptability and sustainability of low-dose high frequency trainings and PartoMa seminars in Hiwot Fana University Hospital.

iv. To document changes in pregnancy outcomes after the introduction of PartoMa approaches-seminars, low dose high frequency trainings, continuous FHR monitoring and tailored interventions-in Hiwot Fana University Hospital.

Setting

PartoMa Ethiopia will be implemented at Haramaya General Hospital and Hiwot Fana Comprehensive Specialized University Hospital, which are both busy maternity units in Eastern Ethiopia. Both are government hospitals with an annual delivery number of around 5,000.

Read the detailed description

METHODS

The embedded study consists of four phases of activities:

I. Baseline assessment, II. Co-creation context specific intrapartum care guideline, III. Implementation of PartoMa seminars, and IV. Post intervention evaluation.

Phase I:

Baseline Assessment of Current Practice (the first three month) Using a mixed method design, detail baseline quality of care assessment will be conducted which include FHR monitoring practice, criterion-based audit of intrapartum management in cases of still births, compliance with obstetric guidelines and basic maternal and child health indicators, through interview of staff, review of records, and observations.

Phase II:

Co-creation of PartoMa guidelines to Ethiopia (month 3-6) Input from the baseline assessment, local birth attendants and stakeholders will be used to adapt the PartoMa guidelines from Tanzania to the hospital context. Together with local birth attendants (doctors and midwifes) evidence from inter(national) adapted to locally achievable guidelines. We will integrate PartoMa Ethiopia with MOYO device for monitoring FHR for improving the still births and supporting the decision-making process. The guideline will be peer reviewed by the international PartoMa team, national consultant obstetricians, and senior midwives.

Phase III:

Introduction of PartoMa Ethiopia in Haramaya Hospital (month 7-18) After completing co-creation of PartoMa Ethiopia guidelines, PartoMa seminars and FHR monitoring will be introduced in Haramaya Hospital. Once PartoMa Ethiopia seminar is introduced, monitoring and evaluation of the process will be conducted. Using the Kirkpatrick's model-which is ideal for evaluating impact of training at different level-will be used for evaluation purpose. Comprehensive data collection, including non-participatory observation of labor ward and interview of birth attendants and the women will be used for data collection (objective II and III). PartoMa seminars will be complemented with real case scenarios obtained from Ethiopian Obstetric Surveillance System (EthOSS) database. Different level of training outcomes will be evaluated following the different level of Following the Kirkpatrick's model, we will evaluate the training outcomes at level one (reaction), level two (learning), level three (behavior), and level four (results).

Phase IV:

Post implementation evaluation and sustainability (Month 19-24) Following implementation of PartoMa Ethiopia packages with MOYO FHR monitoring for 12 months, final data collection will be done following similar approach: the same measuring tools, data collection technique and outcomes.

02

Conditions studied

  • Stillbirth
  • Obstetric Complication
  • Maternal Death
  • Perinatal Death
  • Perinatal Morbidity

Keywords

  • Obstetrics
  • perinatal
  • maternal
  • Intrapartum
  • Quality
  • PartoMa
  • LDHF
03

In context

Stillbirth

121 studies on the registry are indexed under Stillbirth; 34 are open to participants now.

This study's planned enrollment of 500 is close to the median of 476 across 65 interventional studies indexed under Stillbirth.

Browse Stillbirth studies →

Lead sponsor

Haramaya Unversity is the lead sponsor of 9 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All women in labour delivering at the study site and their outcome, July - September 2023 and July -September 2025
  • All birth attendant at the study site in obstetrics and gynecology departments during the baseline and intervention period, July - September 2023 and July -September 2025

Exclusion criteria

Exclusion Criteria:

  • NA
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
500 participants (estimated)

Study arms

  • Experimental
    woman in labor

    All women in labour during the study period (3 months baseline and the 3rd-6th month of the intervention) will be included for this pre- vs post-study of the PartoMa intervention. The following subgroups will be studied in-depth: 1. All stillbirths 2. 5th Minute APGAR score \<7 3. All maternal deaths 4. All women with severe obstetric complication (postpartum hemorrhage, hypertensive disorders of pregnancy, uterine rupture, obstructed labor)

    Other: PartoMa intervention(Locally achievable intrapartum care guideline), in house LDHF trainings

  • Experimental
    Birth attendants

    All health care providers (physicians and midwives) working at the department of obstetrics during the study period will be invited to participate in knowledge tests of obstetric care and qualitative study. participant observations as well as in-depth interviews regarding quality of intrapartum care. This is a part of evaluating the use and effectiveness of the PartoMa intervention.

    Other: PartoMa intervention(Locally achievable intrapartum care guideline), in house LDHF trainings

Interventions

  • OtherPartoMa intervention(Locally achievable intrapartum care guideline), in house LDHF trainings

    We will implement PartoMa interventions: seminars, LDHF training, and supportive supervision

    Also known as: LDHF trainings, Partograph

06

What researchers measure

Primary outcomes

  1. stillbirth

    Still birth= fetal death after 28 wk of gestation or weighing \>/= 1000g (both with /without positive fetal heart rate on admission).

    Time frame: A comparison of the baseline (July - September 2023) with 6th -9th month of the intervention

  2. Birth Asphyxia

    newborns with a 5minute APGAR score \<7

    Time frame: A comparison of the baseline (July - September 2023) with 6th -9th month of the intervention

Secondary outcomes

  1. Maternal death

    Deaths of women at the study site while pregnant or within 42 days postpartum, from any cause related to or aggravated by pregnancy or its management

    Time frame: A comparison of the baseline (July - September 2023) with 6th -9th month of the intervention

  2. Cesarean sections and vacuum extractions

    All woman who gave birth through Cesarian Sections and Vacuum extractions

    Time frame: A comparison of the baseline (July - September 2023) with 6th -9th month of the intervention

  3. Process indicators of quality of intrapartum care

    This includes partograph utilization, timely monitoring of ( fetal heart rate, labour progress, and maternal vital signs), and oxytocin use for labour augmentation. Management is compared to pre-selected audit criteria.Management will be compared to pre-selected audit criteria

    Time frame: A comparison of the baseline (July - September 2023) with 6th -9th month of the intervention

  4. Birth attendant's perception of their work condition in the labour and delivery rooms

    Participant observations and in-depth interviews

    Time frame: A comparison of the baseline (July - September 2023) with 6th -9th month of the intervention

  5. The women's experience of care received during delivery.

    By focus group discussion

    Time frame: A comparison of the baseline (July - September 2023) with 6th -9th month of the intervention

07

Study locations

1 of 2 sites recruiting
  • Haramaya Hospital
    Harar, Oromia, Ethiopia
    Recruiting
    • Roba Ararsa, MD · Contact
  • Hiwot Fana University Hospital
    Harar, Ethiopia
    Not yet recruiting
    • Redwan Ahmed, MD · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06273007
Lead sponsor
Haramaya Unversity
Responsible party
ABERA KENAY TURA (Dr., Haramaya Unversity) — Principal investigator
First posted
Feb 22, 2024
Start date
Jun 1, 2023
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Feb 22, 2024

Study contacts

Abera Tura, PhD
Contact
daberaf@gmail.com
+251912048026
Habtamu Bekele, MSc
Contact
habti.bekele@gmail.com
+251917440496

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion